Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02243774 · ClinicalTrials.gov registry record · NA
Mail Outreach To Increase Vaccination Acceptance Through Engagement
A NA study of Influenza and Influenza, Human, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 228,000
- Enrollment target
- 1
- Study location
NCT02243774 is a NA study of Influenza and Influenza, Human that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 228,000 participants, above the 35,342-participant average among 156 other Influenza trials with a reported enrollment target (545% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02243774, a NA study of Influenza and Influenza, Human, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 228,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine whether receiving a core letter signed by the Surgeon General or the Director of the National Vaccine Program that provides only information about influenza, or a core letter signed by the Surgeon General with an added basic or enhanced implementation prompt, will increase rates of influenza vaccination among Medicare beneficiaries when compared to a control group.
Conditions Studied
Interventions
- BEHAVIORAL Core letter signed by Surgeon General
- BEHAVIORAL Core letter signed by the Director of the National Vaccine Program
- BEHAVIORAL Core letter signed by Surgeon General + implementation prompt
- BEHAVIORAL Core letter signed by SG + enhanced implementation prompt
Study Locations (1)
Maryland
- Centers for Medicare & Medicaid Services - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228,000 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02243774
The ClinicalTrials.gov registry entry for NCT02243774 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 228,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 35,342-participant average among 156 other Influenza trials with a reported enrollment target (545% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Influenza appearing as the primary indexed condition, and to 4 interventions - of which Core letter signed by Surgeon General is the first listed.
NCT02243774 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02243774 about?
NCT02243774 is a clinical study titled "Mail Outreach To Increase Vaccination Acceptance Through Engagement". The aim of this study is to determine whether receiving a core letter signed by the Surgeon General or the Director of the National Vaccine Program that provides only information about influenza, or a core letter signed by the Surgeon General with an added basic or enhanced implementation prompt, wi...
What is the current status of trial NCT02243774?
This trial is currently completed. It is a NA study. The enrollment target is 228,000 participants. The study started on 2014-09. Estimated completion is 2015-09.
What conditions does trial NCT02243774 study?
This clinical trial studies the following conditions: Influenza, Influenza, Human, Human Flu.
What interventions are being tested in trial NCT02243774?
The interventions under investigation include: Core letter signed by Surgeon General (BEHAVIORAL), Core letter signed by the Director of the National Vaccine Program (BEHAVIORAL), Core letter signed by Surgeon General + implementation prompt (BEHAVIORAL), Core letter signed by SG + enhanced implementation prompt (BEHAVIORAL).
Who is sponsoring clinical trial NCT02243774?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02243774 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Immune Defense Protein Impact On Respiratory Immune Outcomes
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
RECRUITING · NA
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.